Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03084874
Other study ID # PR(AG)390/2015
Secondary ID
Status Recruiting
Phase N/A
First received March 14, 2017
Last updated March 14, 2017
Start date March 2017
Est. completion date December 2018

Study information

Verified date March 2017
Source Hospital Universitari Vall d'Hebron Research Institute
Contact Maria A Ramon, PT, PhD
Phone 0034932746107
Email maramon@vhebron.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with COPD are more inactive and more sedentary than subjects of the same age and patients with other chronic diseases. This inactivity and sedentary behavior is accentuated after hospitalizations due to a COPD exacerbation, and it increases the risk for future hospitalizations and mortality. Therefore, there is a need for intervention to promote physical activity and to reduce sedentary behavior after these events. The present study aims to evaluate the efficacy of a coaching program to promote physical activity and reduce sedentary behavior in patients with COPD who have suffered a hospitalization due to a COPD exacerbation. Sixty-six COPD patients admitted to the hospital will be recruited during 18 months. Physical activity, sedentary behaviors, as well as other clinical and functional parameters will be evaluated after hospital discharge. Patients will be then randomized to an intervention and control group (1:1). The intervention group will receive an individualized coaching program. During a motivational interview an experienced physiotherapist will asses participant's usual exercise habits, possible barriers and facilitators, self-efficacy and motivation to increase physical activity and reduce sedentary time. Based on these data (and baseline physical activity/sedentary information) an individualized, progressive program with specific goals setting and self-monitoring will be established (patients will be active participants and decision makers in this process). The control group will receive the usual care during follow-up. Physical activity, sedentary behaviors, as well as the clinical and functional variables will be evaluated again at 12 weeks in both patients' groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 66
Est. completion date December 2018
Est. primary completion date September 2018
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria:

1. Previous diagnosis of COPD according to spirometric criteria (post-bronchodilator FEV1 / FVC less than 70%)

2. Smoking exposure> 10 paq/year.

3. Age greater than 40 years.

4. Hospitalization due to a COPD exacerbation

5. Written informed consent.

Exclusion Criteria:

1. Patients needing the care of an Intensive Care Unit.

2. Patients who have been hospitalized more than once for a COPD exacerbation in the previous 12 months (at least 3 months from last discharge).

3. Patients with continuous oxygen therapy who do not have a portable source before admission.

4. Patients with severe hypoxemia at rest (SpO2 <85% at rest) at discharge

5. Mental incapacity, severe comorbidity, general fragility or advanced age that could substantially difficult patient's participation in the study.

6. Patients who need mechanical aids for walking.

7. Patients participating in a pulmonary rehabilitation program.

8. Difficulty understanding Spanish / Catalan.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Physical activity and sedentary behavior coaching program
The intervention group will receive an individualized coaching program. During a motivational interview an experienced physiotherapist will asses participant's usual exercise habits, possible barriers and facilitators, self-efficacy and motivation to increase physical activity and reduce sedentary time. Based on these data (and baseline physical activity/sedentary information) an individualized, progressive program with specific goals setting and self-monitoring will be established (patients will be active participants and decision makers in this process).

Locations

Country Name City State
Spain University Hospital Vall d'Hebron Barcelona

Sponsors (2)

Lead Sponsor Collaborator
Hospital Universitari Vall d'Hebron Research Institute Spanish Society of Pneumology and Thoracic Surgery

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in patients's anxiety and depression Patient's anxiety and depression measured using the Hospital Anxiety and Depression scale (HADS) Baseline and 12 weeks
Other Change in dyspnoea during daily activities Dyspnoea during daily activities measures using the London Chest Activity of Daily Living scale (LCADL) Baseline and 12 weeks
Primary Change in steps per day Steps per day will be objectively measured with an accelerometer Baseline and 12 weeks
Primary Change in the number of active periods per day Number of periods spent standing, walking or shuffling objectively measured with an accelerometer Baseline and 12 weeks
Primary Change in time spend in light and moderate physical activity Time spend in light and moderate physical activity (1.5-3 and 3-6 METS) objectively measured with an accelerometer Baseline and 12 weeks
Primary Change in time spend in sedentary behavior Time spend in sedentary behavior (sitting or lying) objectively measured with an accelerometer Baseline and 12 weeks
Primary Breaks in sedentary behaviour Number of transitions from sedentary behavior to standing or walking objectively measured with an accelerometer Baseline and 12 weeks
Secondary Change in exercise capacity Distance walked in the 6-minute walk test Baseline and 12 weeks
Secondary Change in muscle force Quadriceps muscle force tested with a hand-held dynamometer Baseline and 12 weeks
Secondary Change in patient's quality of life patient's quality of life measured using the St. George's Respiratory Questionnaire (SGRQ) anbd the COPD assesment test (CAT) Baseline and 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy